News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all News
Wolfe BioPharma Conference "Emerging Markets and Technology" 2010 Vision
October 19, 2010Location: The Ritz Carlton
Boston, Massachusetts
8:30am - 9:00 am - Keynote Speaker: G. Steven Burrill, CEO, Burrill & Company
The 2010 Wolfe Biopharma Conference, Emerging Markets and Technologies: 2020 VisionTM, is an exclusive, invitation-only event for pharmaceutical and biotechnology executives and investors. The pharmaceutical industry is undergoing rapid transformation, necessitating redeployment of their resources, strategies and organizations toward emerging markets and technologies. Healthcare policy reform, the global economic crisis, and large pharmas’ imminent patent cliff have converged while unique opportunities in emerging markets and technological innovations seem to appear with increasing frequency. At the 2010 Wolfe Biopharma Conference, industry leaders will address these challenges and opportunities.
back to Events list